Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial.
Benjamin LiJose AlvirMichelle StewartPublished in: Cardiology and therapy (2020)
ClinicalTrials.gov: NCT01994889.